Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyAntigens, CD34Hematologic NeoplasmsBlood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationHematopoietic Stem CellsEtoposideThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisHodgkin DiseaseDisease-Free SurvivalCord Blood Stem Cell TransplantationTransplantation ChimeraRetrospective StudiesNeoplasmsTissue DonorsSurvival RateWhole-Body IrradiationSurvival AnalysisInfectionTime FactorsLymphoma, T-CellDoxorubicinHistocompatibilityPlatelet CountPOEMS SyndromeCarboplatinPrednisoneHistocompatibility TestingImmunosuppressive AgentsLeukemia, Myeloid, AcuteTransplantation, IsogeneicVidarabineBlood Cell CountDexamethasoneRecombinant ProteinsFollow-Up StudiesLeukemiaBone Marrow PurgingAntineoplastic AgentsBlood CellsLymphomaProspective StudiesCytomegalovirus InfectionsGraft vs Leukemia EffectFeasibility StudiesFatal OutcomeMyelodysplastic SyndromesImmunophenotypingAnemia, AplasticBlood Transfusion, AutologousLymphocyte DepletionLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveT-LymphocytesLeukocytes, MononuclearHematologic DiseasesBlood DonorsHistiocytosis, Non-Langerhans-CellLivedo ReticularisBone MarrowOpportunistic InfectionsPrognosisBreast NeoplasmsPrecursor Cell Lymphoblastic Leukemia-LymphomaHLA AntigensCyclosporineCell SeparationImmunosuppressionMesenchymal Stem Cell Transplantation